887 related articles for article (PubMed ID: 18045728)
1. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
2. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
3. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
4. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
Pouton CW; Porter CJ
Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
[TBL] [Abstract][Full Text] [Related]
5. Developing early formulations: practice and perspective.
Li P; Zhao L
Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
[TBL] [Abstract][Full Text] [Related]
6. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
8. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
10. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
Müllertz A; Ogbonna A; Ren S; Rades T
J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
[TBL] [Abstract][Full Text] [Related]
11. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
[TBL] [Abstract][Full Text] [Related]
12. Thiolated chitosans: useful excipients for oral drug delivery.
Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
14. What determines drug solubility in lipid vehicles: is it predictable?
Rane SS; Anderson BD
Adv Drug Deliv Rev; 2008 Mar; 60(6):638-56. PubMed ID: 18089295
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
16. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
17. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
18. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
Chakraborty S; Shukla D; Mishra B; Singh S
Eur J Pharm Biopharm; 2009 Sep; 73(1):1-15. PubMed ID: 19505572
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based formulations for oral administration of poorly water-soluble drugs.
Mu H; Holm R; Müllertz A
Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]